Valhi (VHI) Q3 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2025 earnings summary
6 Nov, 2025Executive summary
Net loss attributable to stockholders was $22.2M ($0.78/share) for Q3 2025 vs. net income of $57.5M ($2.01/share) in Q3 2024; nine-month net loss was $4.4M ($0.15/share) vs. net income of $85.2M ($2.99/share) year-over-year.
Losses driven by lower Chemicals segment performance, non-cash deferred tax expense from German tax law changes, and absence of prior year’s $64.5M gain on TiO2 JV/LPC remeasurement.
Real Estate and Component Products segments showed improved operating income year-over-year.
Financial highlights
Q3 2025 revenues: $524.1M (or $503.5M per alternate source), down from $558.8M ($533.6M) in Q3 2024; nine-month revenues: $1.635B ($1.58B), down from $1.665B ($1.62B).
Q3 2025 net loss: $21.9M; nine-month net loss: $4.4M.
Q3 2025 operating income was $8.6M, down from $67.7M in Q3 2024; nine-month operating income was $94.2M, down from $154.0M.
Cash and equivalents at period end: $223.9M, down from $365.1M at prior year-end.
Q3 2025 interest expense increased to $14.9M from $13.4M; nine-month interest expense rose to $41.9M from $36.6M.
Outlook and guidance
2025 consolidated operating income expected to be lower than 2024, mainly due to weaker Chemicals segment performance.
Real Estate and Component Products segments expected to show higher operating income in 2025.
Chemicals segment does not expect near-term sales volume improvement; further operating rate reductions planned to align with demand.
Management notes ongoing global uncertainty in the TiO2 industry due to trade policies, geopolitical tensions, and customer inventory hesitancy, prolonging the market downturn.
Latest events from Valhi
- Net loss in 2025 driven by weak Chemicals results, lower TiO2 prices, and higher costs.VHI
Q4 202510 Mar 2026 - Dixie Rice's majority stake ensures approval of all board and compensation proposals.VHI
Proxy Filing2 Dec 2025 - Annual meeting to elect seven directors and hold a say-on-pay vote, with online voting available.VHI
Proxy Filing2 Dec 2025 - Net income dropped sharply as Chemicals weakened and interest expense increased.VHI
Q2 20257 Aug 2025 - Q3 2024 net income surged to $57.5M on Chemicals strength and LPC acquisition gains.VHI
Q3 202413 Jun 2025 - Q2 profit surged to $19.9M as Chemicals volumes rose and costs fell, despite higher interest.VHI
Q2 202413 Jun 2025 - Q1 net income surged on Chemicals growth and LPC acquisition, with a strong 2025 outlook.VHI
Q1 20256 Jun 2025 - Valhi's 2024 profit surge was fueled by Chemicals Segment strength and strategic acquisitions.VHI
Q4 20245 Jun 2025